59-42-7 | 去氧肾上腺素碱
英文名称
Phenylephrine
EINECS/EC编号
200-424-8
分子式
C9H13NO2
分子量
167.21
MDL编号
MFCD00044749
结构式
中文别名
英文别名
| 属性 | 值 |
|---|---|
| InChI | InChI=1/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/s3 |
| SMILES | [C@H](C1C=CC=C(O)C=1)(O)CNC |&1:0,r| |
| 密度 | 1.1222 (rough estimate) |
| 形态 | neat |
| 沸点 | 295.79°C (rough estimate) |
| 熔点 | 171°C |
| 颜色 | 白色至灰白色 |
| InChIKey | SONNWYBIRXJNDC-DJEYLCQNNA-N |
| 折射率 | -55.5 ° (C=5, 1mol/L HCl) |
| 溶解度 | Slightly soluble in water, sparingly soluble in methanol, slightly soluble in ethanol (96 per cent). It dissolves in dilute mineral acids and in dilute solutions of alkali hydroxides. |
| 储存条件 | -20°C Freezer, Under inert atmosphere |
| CAS 数据库 | 59-42-7(CAS DataBase Reference) |
| 酸度系数(pKa) | pKa 8.9 (Uncertain) |
| NIST化学物质信息 | Benzenemethanol, 3-hydroxy-«alpha»-[(methylamino)methyl]-, (r)-(59-42-7) |
| 属性 | 值 |
|---|---|
| 毒性 | LD50 oral in rat: 350mg/kg |
| RTECS号 | DO7175000 |
| 警示词 | 危险 |
| 安全说明 | S26-S36-S45 |
| 海关编码 | 2922.19.7000 |
| 防范说明 | P261-P264-P280-P301+P312-P302+P352-P305+P351+P338 |
| 危险品标志 | Xn |
| 危险性描述 | H302-H315-H318-H335 |
| 危险类别码 | R22-R36/37/38 |
| 毒害物质数据 | 59-42-7(Hazardous Substances Data) |
| 危险性符号(GHS) | GHS05,GHS07 |
| 标题 | 内容 |
|---|---|
| 用途一 | 拟肾上腺素药物,用于外科手术延长局部麻醉时间、鼻粘膜充血、急性低血压、感染中毒性及过敏性休克等症 |
| 标题 | 内容 |
|---|---|
| 体内研究 | Perfusion of hearts with 100 μM phenylephrine causes a rapid (maximal at 10 min) 12-fold activation of two p38-MAPK isoforms. α 1 -adrenoceptor agonists such as phenylephrine increase the contractility of the heart. Phenylephrine also activates SAPKs/JNKs in neonatal ventricular myocytes. Phenylephrine could increase the alveolar fluid clearance in high tidal volume-ventilated rats and accelerate the absorption of pulmonary edema. |
| 体外研究 | (R)-(-)-Phenylephrine is a selective α 1 -adrenoceptor agonist with pK i values of 5.86, 4.87 and 4.70 for α 1D , α 1B and α 1A receptors respectively. Phenylephrine promotes cardiac fibroblast proliferation. Phenylephrine activates CaN and evokes NFAT3 nuclear translocation. It suggests that the Ca( 2+ )/CaN/NFAT pathway mediates phenylephrine -induced cardiac fibroblast proliferation, and this pathway might be a possible therapeutic target in cardiac fibrosis. |
| 生物活性 | (R)-(-)-Phenylephrine是选择性的α1-肾上腺素受体激动剂,主要用作减充血剂。 |
59-42-7
相关产品
| 商城编码 | 产品名称 | 标准值 | 规格 | CAS号 | 库存 | 标准价 | 品牌 | 数量 | 操作 |
|---|---|---|---|---|---|---|---|---|---|
| SHAM_129644 | L-苯肾上腺素标准品|SHAM_129644|99.7%|10mg|CAS:59-42-7 |
99.7%
|
10mg
|
59-42-7
|
0
|
咨询
|
伟业计量
|
|
|
| ZC-52294 | Phenylephrine|ZC-52294|≥98%|500 mg|CAS:59-42-7 |
≥98%
|
500 mg
|
59-42-7
|
0
|
840.0
|
萘析精选
|
|
|
| CCAD302336 | L-苯肾上腺素|CCAD302336|99.4%|250mg|CAS:59-42-7 |
99.4%
|
250mg
|
59-42-7
|
0
|
480.0
|
CATO
|
|
|
| CCAD302336 | L-苯肾上腺素|CCAD302336|99.4%|100mg|CAS:59-42-7 |
99.4%
|
100mg
|
59-42-7
|
0
|
240.0
|
CATO
|
|
|
| CCAD302336 | L-苯肾上腺素|CCAD302336|99.4%|10mg|CAS:59-42-7 |
99.4%
|
10mg
|
59-42-7
|
0
|
100.0
|
CATO
|
|
|
| CCAD302336 | L-苯肾上腺素|CCAD302336|99.4%|25mg|CAS:59-42-7 |
99.4%
|
25mg
|
59-42-7
|
0
|
100.0
|
CATO
|
|
|
| CCAD302336 | L-苯肾上腺素|CCAD302336|99.4%|1mg|CAS:59-42-7 |
99.4%
|
1mg
|
59-42-7
|
0
|
咨询
|
CATO
|
|
|
| ZTR-P320688 | L-Phenylephrine|ZTR-P320688|100mg|CAS:59-42-7 |
见证书
|
100mg
|
59-42-7
|
0
|
咨询
|
萘析精选
|
|
|
| ZLG-MM0287.00 | Phenylephrine|ZLG-MM0287.00|250mg|CAS:59-42-7 |
见证书
|
250mg
|
59-42-7
|
0
|
25540.0
|
萘析精选
|
|
|
| 1ST10940-10mg | L-苯肾上腺素|1ST10940-10mg|98.6%|CAS:59-42-7 |
98.6%
|
10mg
|
59-42-7
|
0
|
80.0
|
First Standard
|
|
| 商城编码 | 产品名称 | 标准值 | 规格 | CAS号 | 库存 | 标准价 | 品牌 | 数量 | 操作 |
|---|---|---|---|---|---|---|---|---|---|
| R054158-5g | L-苯肾上腺素|R054158-5g|≥98%|CAS:59-42-7 |
≥98%
|
5g
|
59-42-7
|
0
|
360.0
|
罗恩
|
|
|
| R054158-1g | L-苯肾上腺素|R054158-1g|≥98%|CAS:59-42-7 |
≥98%
|
1g
|
59-42-7
|
0
|
120.0
|
罗恩
|
|
|
| S80819-1g | L-苯肾上腺素|S80819-1g|98%|CAS:59-42-7 |
98%
|
1g
|
59-42-7
|
4
|
110.0
|
源叶
|
|
|
| S80819-25g | L-苯肾上腺素|S80819-25g|98%|CAS:59-42-7 |
98%
|
25g
|
59-42-7
|
0
|
1070.0
|
源叶
|
|
|
| S80819-5g | L-苯肾上腺素|S80819-5g|98%|CAS:59-42-7 |
98%
|
5g
|
59-42-7
|
1
|
314.0
|
源叶
|
|
|
| V54942-1ml | L-苯肾上腺素|V54942-1ml|10mM in DMSO|CAS:59-42-7 |
10mM in DMSO
|
1ml
|
59-42-7
|
0
|
450.0
|
源叶
|
|
|
| Merck-S#P1240000 | L-苯肾上腺素|L-Phenylephrine|59-42-7|Merck|1EA|Merck-S#P1240000 |
见证书
|
1EA
|
59-42-7
|
0
|
1747.61
|
Merck
|
|
|
| 17205-1 g | L-Phenylephrine|17205-1 g|CAS:59-42-7 |
见详情
|
1 g
|
59-42-7
|
0
|
844.2
|
萘析精选
|
|
|
| 17205-10 g | L-Phenylephrine|17205-10 g|CAS:59-42-7 |
见详情
|
10 g
|
59-42-7
|
0
|
2452.2
|
萘析精选
|
|
|
| 17205-5 g | L-Phenylephrine|17205-5 g|CAS:59-42-7 |
见详情
|
5 g
|
59-42-7
|
0
|
1447.2
|
萘析精选
|
|
| 商城编码 | 产品名称 | 标准值 | 规格 | CAS号 | 库存 | 标准价 | 品牌 | 数量 | 操作 |
|---|---|---|---|---|---|---|---|---|---|
| ZEP-P1240000-A1A | PHENYLEPHRINE CRS|ZEP-P1240000-A1A|unit|CAS:59-42-7 |
见证书
|
unit
|
59-42-7
|
0
|
1850.0
|
萘析精选
|
|